Standard BioTools (STU:FLB) Institutional Ownership: 11.96% (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FLB Standard BioTools Inc STU:FLB
37 GF Score
Price €0.69
GF Value €0.60
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Standard BioTools Institutional Ownership?

Standard BioTools STU:FLB -0.72% 37 Institutional Ownership is 11.96% as of Aug. 08, 2026. GuruFocus rates STU:FLB with a GF Score™ of 37/100 and a GF Value™ of €0.60 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Standard BioTools's institutional ownership is 11.96%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Standard BioTools's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Standard BioTools's Float Percentage Of Total Shares Outstanding is 60.66%.

Standard BioTools Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Standard BioTools's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard BioTools Institutional Ownership Chart

Standard BioTools Historical Data

The historical data trend for Standard BioTools can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 23.55 23.46 22.83 22.59 22.69 19.06 18.89 18.64 12.25 11.96
STU:FLB
37GF Score
Standard BioTools Inc STU:FLB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard BioTools Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 11.96% mean?
Standard BioTools (STU:FLB) has a Institutional Ownership of 11.96% as of Aug. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Standard BioTools and its competitors.
Is Standard BioTools' Institutional Ownership too high?
Standard BioTools' current Institutional Ownership is 11.96%. Overall, Standard BioTools has a GF Score™ of 37/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Standard BioTools' Institutional Ownership compare to CV and ELMD?
Standard BioTools' Institutional Ownership of 11.96% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Standard BioTools and its competitors. Standard BioTools's current Institutional Ownership is 11.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard BioTools stock overvalued right now?
Based on GuruFocus' analysis, Standard BioTools (STU:FLB) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.60, compared to a current price of €0.69 — trading 14.2% above its estimated fair value. The current Institutional Ownership is 11.96%. Standard BioTools' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Standard BioTools (STU:FLB), the current Institutional Ownership is 11.96% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard BioTools (STU:FLB) Overvalued in 2026?

Based on GuruFocus' analysis, Standard BioTools stock appears to be overvalued. The current stock price of €0.69 is trading 14.2% above its estimated GF Value™ of €0.60. GuruFocus considers Standard BioTools to be Modestly Overvalued.

Key valuation signals for STU:FLB:

  • Institutional Ownership: 11.96%
  • GF Value™: €0.60 vs. price of €0.69 (14.2% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the STU:FLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Standard BioTools Business Description

Other Exchanges LAB:USA
Address 50 Milk Street, 10th Floor, Boston, MA, USA, 02109
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
37GF Score

Get the complete analysis for STU:FLB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.69
Price
€0.60
GF Value